The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Franken Michael since year 2005.
The trader's CIK number is 1551439.
At the time of this reporting, Franken Michael is the President, Biosimilars Busines of Momenta Pharmaceuticals Inc .
(stock ticker symbol MNTA).
See this page for all insider trading activities at Momenta Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-12-11||MNTA||Momenta Pharmaceuticals Inc||Sale||520||15.84||8,236|
|2015-09-11||MNTA||Momenta Pharmaceuticals Inc||Sale||513||18.92||9,705|
|2015-08-10||MNTA||Momenta Pharmaceuticals Inc||Sale||20,000||22.36||447,200|
|2015-08-10||MNTA||Momenta Pharmaceuticals Inc||Option Ex||20,000||17.23||344,600|
|2015-06-11||MNTA||Momenta Pharmaceuticals Inc||Sale||512||22.37||11,453|
|2015-03-11||MNTA||Momenta Pharmaceuticals Inc||Sale||512||14.71||7,531|
|2014-12-11||MNTA||Momenta Pharmaceuticals Inc||Sale||2,047||12.29||25,157|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Franken Michael (President, Biosimilars Busines of Momenta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.